Recently, researchers have observed higher levels of METTL3, ALKBH5, METTL14 and IGF2BP1 in chemotherapy-resistant OS cells [173, 193, 207], and METTL14 and YTHDF2 are associated with multiple drug sensitivity in Ewing's sarcoma. This evidence concerns the gene METTL3 and Ewing sarcoma.